Literature DB >> 12211879

Understanding predisposition to schizophrenia: toward intervention and prevention.

Ming T Tsuang1, William S Stone, Stephen V Faraone.   

Abstract

OBJECTIVE: Early intervention to prevent schizophrenia is one of the most important goals of schizophrenia research. However, the field is not yet ready to initiate trials to prevent prodromal or psychotic symptoms in people who are at risk for developing the disorder. In this paper, we consider some of the major obstacles that must be studied before prevention strategies become feasible. METHOD AND
RESULTS: One of the most important hurdles is the identification of a syndrome or set of traits that reflects a predisposition to schizophrenia and that might provide potential targets for intervention. In a recent reformulation of Paul Meehl's concept of schizotaxia, we integrate research findings obtained over the last 4 decades to propose a syndrome with meaningful clinical manifestations. We review the conceptualization of this syndrome and consider its multidimensional clinical expression. We then describe preliminary research diagnostic criteria for use in adult, nonpsychotic, first-degree relatives of patients diagnosed with schizophrenia, based on negative symptoms and neuropsychological deficits. We follow this with evidence supporting the validity of the proposed syndrome, which mainly includes social dysfunction and response to a low dosage of one of the newer antipsychotic medications.
CONCLUSIONS: Continued progress toward the eventual initiation of prevention strategies for schizophrenia will include sustained efforts to validate the traits reflecting a predisposition to develop the disorder (for example, schizotaxia), follow-up studies to confirm initial findings, and the identification of potentially useful preventive interventions.

Entities:  

Mesh:

Year:  2002        PMID: 12211879     DOI: 10.1177/070674370204700603

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  10 in total

1.  Gene-environment interactions in mental disorders.

Authors:  Ming T Tsuang; Jessica L Bar; William S Stone; Stephen V Faraone
Journal:  World Psychiatry       Date:  2004-06       Impact factor: 49.548

2.  The Evolution of Evidence-based Practices.

Authors:  Anthony Biglan; Terje Ogden
Journal:  Eur J Behav Anal       Date:  2008

3.  A case-control study of personality style and psychopathology in parents of subjects with autism.

Authors:  Sven Bölte; Susan Knecht; Fritz Poustka
Journal:  J Autism Dev Disord       Date:  2007-02

4.  Clinical, cognitive, and social characteristics of a sample of neuroleptic-naive persons with schizotypal personality disorder.

Authors:  Chandlee C Dickey; Robert W McCarley; Margaret A Niznikiewicz; Martina M Voglmaier; Larry J Seidman; Sunnie Kim; Martha E Shenton
Journal:  Schizophr Res       Date:  2005-10-15       Impact factor: 4.939

5.  Convergent and divergent gray matter volume abnormalities in unaffected first-degree relatives and ultra-high risk individuals of schizophrenia.

Authors:  Bei Lin; Xian-Bin Li; Sen Ruan; Yu-Xin Wu; Chao-Yue Zhang; Chuan-Yue Wang; Lu-Bin Wang
Journal:  Schizophrenia (Heidelb)       Date:  2022-06-04

Review 6.  Developing therapeutics for schizophrenia and other psychotic disorders.

Authors:  Gerard Marek; Kalpana Merchant
Journal:  NeuroRx       Date:  2005-10

Review 7.  Comparison groups in autism family research: Down syndrome, fragile X syndrome, and schizophrenia.

Authors:  Marsha Mailick Seltzer; Leonard Abbeduto; Marty Wyngaarden Krauss; Jan Greenberg; April Swe
Journal:  J Autism Dev Disord       Date:  2004-02

Review 8.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

Review 9.  Do subjects at clinical high risk for psychosis differ from those with a genetic high risk?--A systematic review of structural and functional brain abnormalities.

Authors:  R Smieskova; J Marmy; A Schmidt; K Bendfeldt; A Riecher-Rӧssler; M Walter; U E Lang; S Borgwardt
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 10.  Treating early psychosis: who, what, and when?

Authors:  Barbara A Cornblatt; Andrea M Auther
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.